Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Directors Deals Ltd.
$12.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Thoratec Corp Narrows FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance


Wednesday, 30 Oct 2013 04:02pm EDT 

Thoratec Corp announced that for fiscal 2013, it is narrowing guidance for revenues to a range of $500 million to $505 million compared with the previous guidance range of $490 million to $510 million. The Company is increasing guidance for net income per diluted share to a range of $1.30 to $1.35 on a GAAP basis and $1.80 to $1.85 on a non-GAAP basis. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $502 million and EPS of $1.75 for fiscal 2013.